Correlation Between Livermore Investments and Cizzle Biotechnology

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Livermore Investments and Cizzle Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Livermore Investments and Cizzle Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Livermore Investments Group and Cizzle Biotechnology Holdings, you can compare the effects of market volatilities on Livermore Investments and Cizzle Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Livermore Investments with a short position of Cizzle Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Livermore Investments and Cizzle Biotechnology.

Diversification Opportunities for Livermore Investments and Cizzle Biotechnology

-0.63
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Livermore and Cizzle is -0.63. Overlapping area represents the amount of risk that can be diversified away by holding Livermore Investments Group and Cizzle Biotechnology Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cizzle Biotechnology and Livermore Investments is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Livermore Investments Group are associated (or correlated) with Cizzle Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cizzle Biotechnology has no effect on the direction of Livermore Investments i.e., Livermore Investments and Cizzle Biotechnology go up and down completely randomly.

Pair Corralation between Livermore Investments and Cizzle Biotechnology

Assuming the 90 days trading horizon Livermore Investments Group is expected to generate 1.32 times more return on investment than Cizzle Biotechnology. However, Livermore Investments is 1.32 times more volatile than Cizzle Biotechnology Holdings. It trades about 0.26 of its potential returns per unit of risk. Cizzle Biotechnology Holdings is currently generating about -0.25 per unit of risk. If you would invest  4,500  in Livermore Investments Group on September 26, 2024 and sell it today you would earn a total of  900.00  from holding Livermore Investments Group or generate 20.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Livermore Investments Group  vs.  Cizzle Biotechnology Holdings

 Performance 
       Timeline  
Livermore Investments 

Risk-Adjusted Performance

21 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Livermore Investments Group are ranked lower than 21 (%) of all global equities and portfolios over the last 90 days. In spite of rather uncertain technical and fundamental indicators, Livermore Investments exhibited solid returns over the last few months and may actually be approaching a breakup point.
Cizzle Biotechnology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Cizzle Biotechnology Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's technical and fundamental indicators remain rather sound which may send shares a bit higher in January 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Livermore Investments and Cizzle Biotechnology Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Livermore Investments and Cizzle Biotechnology

The main advantage of trading using opposite Livermore Investments and Cizzle Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Livermore Investments position performs unexpectedly, Cizzle Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cizzle Biotechnology will offset losses from the drop in Cizzle Biotechnology's long position.
The idea behind Livermore Investments Group and Cizzle Biotechnology Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.

Other Complementary Tools

Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios